| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
4e-05 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |